Hecht Beth
Insider CIK 1652410 · XERS See Remarks · AYTU Director · NEOS Director · ITRM Director · XERS See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings, | S Sale | 2026-10-01 | 2026-10-02 | 16,666 | $9.41 | $156.8K | 1,111,130 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-09-01 | 2026-09-01 | 16,666 | $8.49 | $141.5K | 1,127,796 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-09-01 | 2026-09-01 | 16,666 | $8.49 | $141.4K | 1,127,796 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-08-03 | 2026-08-04 | 16,666 | $8.01 | $133.5K | 1,144,462 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-08-03 | 2026-08-04 | 16,666 | $8.01 | $133.6K | 1,144,462 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-07-01 | 2026-07-02 | 16,666 | $8.03 | $133.8K | 1,161,128 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-06-01 | 2026-06-02 | 16,667 | $6.06 | $101.0K | 1,176,506 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-05-01 | 2026-05-01 | 16,667 | $6.23 | $103.8K | 1,193,173 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-04-01 | 2026-04-03 | 16,667 | $5.99 | $99.8K | 1,209,840 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-03-02 | 2026-03-04 | 100 | $7.06 | $706 | 1,226,507 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-03-02 | 2026-03-04 | 16,567 | $6.24 | $103.4K | 1,226,607 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-02-02 | 2026-02-02 | 16,667 | $7.45 | $124.2K | 1,243,174 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 98,375 | $7.36 | $724.0K | 1,331,021 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 24,266 | $7.36 | $178.6K | 1,259,841 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 46,914 | $7.36 | $345.3K | 1,284,107 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2026-01-30 | 2026-02-02 | 162,162 | — | $0 | 162,162 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2026-01-30 | 2026-02-02 | 121,293 | — | $0 | 1,429,396 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-01-02 | 2026-01-05 | 16,667 | $7.43 | $123.8K | 1,308,103 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2025-12-01 | 2025-12-02 | 16,667 | $7.01 | $116.8K | 1,320,176 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2025-11-11 | 2025-11-13 | 16,667 | $7.40 | $123.3K | 1,336,843 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2025-03-20 | 2025-03-21 | 40,000 | $5.43 | $217.2K | 1,353,510 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2025-01-31 | 2025-02-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-31 | 2025-02-03 | 45,909 | $3.56 | $163.4K | 1,306,885 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2025-01-31 | 2025-02-03 | 185,000 | — | $0 | 1,393,510 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-31 | 2025-02-03 | 98,375 | $3.56 | $350.2K | 1,208,510 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-03 | 2025-01-07 | 32,039 | $3.61 | $115.7K | 1,352,794 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-31 | 2024-08-09 | 45,909 | $2.46 | $112.9K | 1,380,802 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2024-01-31 | 2024-01-31 | 750,000 | — | $0 | 1,554,968 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-29 | 2024-08-09 | 19,675 | $2.66 | $52.3K | 1,426,711 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-03 | 2024-08-09 | 33,488 | $2.24 | $75.0K | 1,446,386 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-06-15 | 2023-06-15 | 15,853 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-06-15 | 2023-06-15 | 15,853 | — | $0 | 18,839 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-31 | 2024-08-09 | 5,784 | $1.24 | $7.2K | 1,479,874 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2023-01-31 | 2023-02-01 | 350,000 | — | $0 | 797,758 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-29 | 2024-08-09 | 21,177 | $1.26 | $26.7K | 1,485,658 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-03 | 2024-08-09 | 33,488 | $1.12 | $37.5K | 1,506,835 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2022-06-23 | 2022-06-24 | 36,798 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2022-06-23 | 2022-06-24 | 36,798 | — | $0 | 44,805 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-06-15 | 2022-06-17 | 237,795 | $0.01 | $2.4K | 237,795 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2022-03-18 | 2022-03-22 | 7,642 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2022-03-18 | 2022-03-22 | 7,642 | — | $0 | 8,007 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2022-01-31 | 2024-08-09 | 4,448 | $2.11 | $9.4K | 1,540,323 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2022-01-29 | 2024-08-09 | 14,037 | $2.11 | $29.6K | 1,544,771 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2022-01-03 | 2022-01-05 | 225,000 | — | $0 | 436,821 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 150,000 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 30,879 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 65,295 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 3,826 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 32,500 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 32,500 | — | $0 | 32,500 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 3,826 | — | $0 | 3,826 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 65,295 | — | $0 | 65,295 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 30,879 | — | $0 | 30,879 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 180,000 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 26,366 | — | $0 | 180,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 180,000 | — | $0 | 206,366 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 26,366 | — | $0 | 26,366 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2021-06-23 | 2021-06-25 | 36,798 | — | $0 | 36,798 | SEC↗ |
| AYTU AYTU BIOPHARMA, INC | A Award | 2021-04-08 | 2021-04-12 | 6,500 | — | $0 | 9,052 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 18,322 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 14,777 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 22,756 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 46,907 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 12,500 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer | 2021-03-19 | 2021-03-19 | 23,453 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2021-03-18 | 2021-03-19 | 7,642 | — | $0 | 7,642 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2021-01-29 | 2021-02-01 | 150,000 | — | $0 | 210,814 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2020-08-14 | 2020-08-17 | 150,000 | — | $0 | 150,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2020-06-30 | 2020-07-15 | 3,731 | $2.26 | $8.4K | 60,814 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award | 2020-06-10 | 2020-06-11 | 23,453 | — | $0 | 23,453 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2020-03-13 | 2020-03-16 | 4,000 | $1.97 | $7.9K | 57,083 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2020-02-14 | 2020-02-18 | 4,000 | $4.15 | $16.6K | 8,083 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2020-01-31 | 2020-03-02 | 45,000 | — | $0 | 53,083 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2019-12-31 | 2020-01-06 | 459 | $5.99 | $2.7K | 4,083 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2019-07-01 | 2019-07-03 | 1,124 | $9.72 | $10.9K | 3,928 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2019-06-13 | 2019-06-17 | 46,907 | — | $0 | 46,907 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2019-02-19 | 2019-02-22 | 2,500 | $10.00 | $25.0K | 2,500 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2019-01-31 | 2019-02-01 | 32,500 | — | $0 | 32,500 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2018-07-02 | 2018-07-03 | 22,756 | — | $0 | 22,756 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2017-07-03 | 2017-07-05 | 18,322 | — | $0 | 18,322 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2016-07-01 | 2016-07-05 | 14,777 | — | $0 | 14,777 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | P Buy deriv | 2015-10-01 | 2015-10-01 | 12,500 | — | $0 | 12,500 | SEC↗ |